In the vast world of chemical compounds, each CAS (Chemical Abstracts Service) number represents a unique molecular identity, serving as a critical identifier for researchers, manufacturers, and regulatory bodies. CAS 616201-80-0, identified as LorcaserinA, is one such compound that holds significant importance within the pharmaceutical industry, particularly for its role in weight management. Understanding the CAS 616201-80-0 properties is essential for anyone involved in its procurement, research, or application.

LorcaserinA, chemically known as 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, possesses a distinct molecular structure that dictates its pharmacological activity. It is characterized by its white powder appearance and specific chemical properties, including a boiling point of 288°C and a flash point of 128°C. These physical and chemical attributes are crucial for determining appropriate handling, storage, and processing conditions. The detailed information available regarding its molecular formula (C11H14ClN) and molecular weight (195.69) further aids in precise quantification and reaction stoichiometry.

The utility of LorcaserinA primarily lies in its application as an appetite suppressant, aiding individuals in managing obesity. Its mechanism of action involves selectively activating serotonin 2C receptors in the brain, which leads to increased feelings of fullness and reduced food intake. This makes it a valuable compound in the development of pharmaceuticals aimed at tackling the growing global health concern of obesity. The consistent supply of high-quality LorcaserinA is therefore vital for ongoing research and potential therapeutic applications.

However, the story of CAS 616201-80-0 also includes its regulatory journey. While it showed efficacy in clinical trials, concerns regarding potential long-term health risks, specifically an increased risk of cancer, led to its withdrawal from the market in the United States. This underscores the complex regulatory landscape that pharmaceutical compounds must navigate. The rigorous evaluation processes and post-market surveillance are designed to ensure public safety, even if it means that some promising compounds may not reach widespread use.

For companies like NINGBO INNO PHARMCHEM CO.,LTD., maintaining a thorough understanding of both the chemical properties and regulatory status of compounds like LorcaserinA is fundamental. We are dedicated to providing access to crucial chemical intermediates and research materials, supporting the pharmaceutical industry's efforts to discover and develop safe and effective treatments. The detailed data associated with CAS 616201-80-0 is a critical resource for ensuring successful project outcomes in pharmaceutical research.